C R Bard Company Profile (NYSE:BCR)

About C R Bard

C R Bard logoC. R. Bard, Inc. (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. It operates through the manufacturing and sale of medical devices segment. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease (PVD), end-stage renal disease (ESRD) and heart arrhythmias. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers and other diseases and disorders. Its surgical specialty products include implanted grafts and fixation devices for hernia and soft tissue repairs.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: BCR
  • CUSIP: 06738310
Key Metrics:
  • Previous Close: $243.24
  • 50 Day Moving Average: $235.76
  • 200 Day Moving Average: $223.18
  • 52-Week Range: $189.72 - $245.42
  • Trailing P/E Ratio: 34.62
  • Foreward P/E Ratio: 18.95
  • P/E Growth: 1.84
  • Market Cap: $17.53B
  • Outstanding Shares: 72,030,000
  • Beta: 0.63
  • Net Margins: 14.31%
  • Return on Equity: 48.48%
  • Return on Assets: 14.81%
  • Debt-to-Equity Ratio: 0.95%
  • Current Ratio: 2.63%
  • Quick Ratio: 2.07%
Additional Links:
Companies Related to C R Bard:

Analyst Ratings

Consensus Ratings for C R Bard (NYSE:BCR) (?)
Ratings Breakdown: 8 Hold Ratings, 6 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.53)
Consensus Price Target: $242.38 (0.41% downside)

Analysts' Ratings History for C R Bard (NYSE:BCR)
DateFirmActionRatingPrice TargetDetails
1/29/2017Barclays PLCReiterated RatingHold$245.00View Rating Details
1/27/2017Needham & Company LLCReiterated RatingHoldView Rating Details
1/27/2017JMP SecuritiesBoost Price Target$240.00 -> $255.00View Rating Details
1/27/2017BMO Capital MarketsReiterated RatingBuyView Rating Details
1/5/2017Raymond James Financial, Inc.UpgradeOutperform -> Strong-Buy$250.00 -> $265.00View Rating Details
1/3/2017Morgan StanleyUpgradeEqual Weight -> Overweight$240.00 -> $260.00View Rating Details
9/27/2016Jefferies Group LLCReiterated RatingHold$237.00View Rating Details
9/16/2016Wells Fargo & CompanyUpgradeMarket Perform -> OutperformView Rating Details
9/15/2016Evercore ISIInitiated CoverageBuy$235.00View Rating Details
7/28/2016Leerink SwannReiterated RatingMarket Perform$240.00 -> $233.00View Rating Details
7/27/2016J P Morgan Chase & CoBoost Price TargetNeutral$214.00 -> $225.00View Rating Details
7/27/2016Citigroup Inc.Boost Price TargetBuy$241.00 -> $265.00View Rating Details
7/27/2016Deutsche Bank AGBoost Price TargetHold$234.00 -> $240.00View Rating Details
7/8/2016Bank of America CorpDowngradeBuy -> NeutralView Rating Details
5/24/2016Piper Jaffray CompaniesReiterated RatingBuy$241.00View Rating Details
3/17/2016NomuraInitiated CoverageNeutral$205.00View Rating Details
1/29/2016Goldman Sachs Group, Inc. (The)Lower Price TargetBuy$214.00 -> $211.00View Rating Details
10/23/2015Brean CapitalReiterated RatingHoldView Rating Details
10/23/2015William BlairReiterated RatingHoldView Rating Details
8/27/2015KeyCorpInitiated CoverageSector WeightView Rating Details
(Data available from 2/23/2015 forward)


Earnings History for C R Bard (NYSE:BCR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/26/2017Q416$2.74$2.77$956.12 million$967.10 millionViewListenView Earnings Details
10/25/2016Q3$2.55$2.64$931.66 million$941.90 millionViewListenView Earnings Details
7/26/2016Q2$2.47$2.54$915.22 million$931.50 millionViewListenView Earnings Details
4/27/2016Q116$2.17$2.34$845.77 million$873.50 millionViewListenView Earnings Details
1/28/2016Q415$2.41$2.43$867.22 million$870.80 millionViewListenView Earnings Details
10/22/2015Q3$2.24$2.28$852.93 million$865.70 millionViewListenView Earnings Details
7/23/2015Q2$2.18$2.27$836.18 million$859.80 millionViewListenView Earnings Details
4/23/2015Q115$2.07$2.10$813.36 million$819.70 millionViewListenView Earnings Details
1/29/2015Q414$2.24$2.29$855.11 million$867.20 millionViewListenView Earnings Details
10/22/2014Q314$2.10$2.15$819.20 million$830.00 millionViewListenView Earnings Details
7/24/2014Q214$2.01$2.06$814.58 million$827.10 millionViewListenView Earnings Details
4/22/2014Q114$1.85$1.91$787.10 million$799.30 millionViewListenView Earnings Details
1/30/2014Q413$1.41$1.42$782.28 million$791.30 millionViewListenView Earnings Details
10/22/2013Q313$1.40$1.50$739.12 million$758.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$1.38$1.42$750.91 million$759.90 millionViewListenView Earnings Details
4/23/2013Q1 2013$1.42$1.44$728.45 million$740.30 millionViewListenView Earnings Details
1/31/2013Q4 2012$1.67$1.70$757.49 million$762.60 millionViewListenView Earnings Details
10/23/2012$1.64$1.64ViewN/AView Earnings Details
7/25/2012$1.64$1.62ViewN/AView Earnings Details
1/31/2012$1.68$1.70ViewN/AView Earnings Details
10/25/2011$1.60$1.62ViewN/AView Earnings Details
7/21/2011$1.57$1.57ViewN/AView Earnings Details
4/21/2011$1.46$1.51ViewN/AView Earnings Details
1/31/2011$1.48$1.54ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for C R Bard (NYSE:BCR)
Current Year EPS Consensus Estimate: $11.64 EPS
Next Year EPS Consensus Estimate: $12.84 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$2.16$2.38$2.24
Q2 20164$2.45$2.47$2.46
Q3 20164$2.54$2.58$2.55
Q4 20164$2.73$2.75$2.74
Q1 20173$2.56$2.64$2.61
Q2 20173$2.80$2.85$2.82
Q3 20173$2.89$2.98$2.92
Q4 20173$2.99$3.19$3.11
Q1 20181$2.88$2.88$2.88
Q2 20181$3.12$3.12$3.12
Q3 20181$3.19$3.19$3.19
(Data provided by Zacks Investment Research)


Current Dividend Information for C R Bard (NYSE:BCR)
Annual Dividend:$1.04
Dividend Yield:0.43%
Dividend Growth:6.80% (3 Year Average)
Payout Ratio:14.77% (Based on Trailing 12 Months of Earnings)
8.93% (Based on Current Year Consensus EPS Estimate)
8.10% (Based on Next Year Consensus EPS Estimate)
Track Record:45 Years of Consecutive Dividend Growth

Dividend History for C R Bard (NYSE:BCR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for C R Bard (NYSE:BCR)
Insider Ownership Percentage: 0.97%
Institutional Ownership Percentage: 86.89%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/21/2017Jim C BeasleyInsiderSell4,390$245.00$1,075,550.00View SEC Filing  
2/14/2017John A DefordVPSell2,788$240.51$670,541.88View SEC Filing  
2/14/2017John H WeilandVice ChairmanSell14,091$240.49$3,388,744.59View SEC Filing  
2/14/2017John P GroetelaarsInsiderSell732$240.49$176,038.68View SEC Filing  
2/14/2017Timothy M RingChairmanSell14,425$240.50$3,469,212.50View SEC Filing  
2/13/2017John A. DefordVPSell469$240.07$112,592.83View SEC Filing  
2/13/2017John H WeilandVice ChairmanSell1,274$240.00$305,760.00View SEC Filing  
2/13/2017Timothy M RingChairmanSell1,767$240.02$424,115.34View SEC Filing  
2/13/2017Timothy P CollinsInsiderSell642$240.30$154,272.60View SEC Filing  
2/10/2017Betty D LarsonVPSell3,292$240.92$793,108.64View SEC Filing  
2/9/2017Jim C BeasleyInsiderSell8,593$239.58$2,058,710.94View SEC Filing  
2/9/2017John A. DefordVPSell5,816$239.58$1,393,397.28View SEC Filing  
2/9/2017John H WeilandVice ChairmanSell14,281$239.54$3,420,870.74View SEC Filing  
2/9/2017Timothy M RingChairmanSell20,324$239.56$4,868,817.44View SEC Filing  
1/31/2017Gail K NaughtonDirectorSell367$236.22$86,692.74View SEC Filing  
1/11/2017John P GroetelaarsInsiderSell573$235.00$134,655.00View SEC Filing  
1/10/2017Frank Lupisella, Jr.VPSell2,945$232.00$683,240.00View SEC Filing  
1/9/2017Frank Lupisella, Jr.VPSell210$232.00$48,720.00View SEC Filing  
12/30/2016Frank Lupisella JrVPSell237$226.00$53,562.00View SEC Filing  
12/30/2016Jim C BeasleyInsiderSell4,709$225.00$1,059,525.00View SEC Filing  
12/12/2016John A. DefordVPSell15,883$218.03$3,462,970.49View SEC Filing  
12/12/2016John H WeilandVice ChairmanSell11,190$219.67$2,458,107.30View SEC Filing  
12/12/2016Sharon M. LuboffInsiderSell6,000$219.00$1,314,000.00View SEC Filing  
10/28/2016Christopher S. HollandInsiderSell5,724$211.12$1,208,450.88View SEC Filing  
9/28/2016Timothy M RingChairmanSell92,293$227.81$21,025,268.33View SEC Filing  
9/26/2016Timothy M RingChairmanSell110,000$228.96$25,185,600.00View SEC Filing  
9/19/2016Betty D LarsonVPSell4,032$225.33$908,530.56View SEC Filing  
9/6/2016John A. DefordVPSell7,928$221.06$1,752,563.68View SEC Filing  
5/27/2016Christopher S HollandCFOSell3,970$219.89$872,963.30View SEC Filing  
5/17/2016John P GroetelaarsInsiderSell1,162$219.88$255,500.56View SEC Filing  
5/12/2016Tommy G ThompsonDirectorSell500$219.52$109,760.00View SEC Filing  
5/5/2016Tony L WhiteDirectorSell1,200$216.19$259,428.00View SEC Filing  
4/28/2016Jim C BeasleyInsiderSell4,709$215.00$1,012,435.00View SEC Filing  
4/27/2016Sharon M LuboffVPSell10,000$210.00$2,100,000.00View SEC Filing  
3/29/2016Christopher S HollandCFOSell1,650$200.00$330,000.00View SEC Filing  
2/25/2016Jim C BeasleyInsiderSell1,113$195.27$217,335.51View SEC Filing  
2/23/2016Frank Lupisella JrVPSell2,300$190.25$437,575.00View SEC Filing  
2/22/2016Christopher S HollandCFOSell618$190.00$117,420.00View SEC Filing  
2/22/2016Patricia G ChristianVPSell3,182$190.00$604,580.00View SEC Filing  
2/17/2016John A. DefordVPSell661$187.44$123,897.84View SEC Filing  
2/17/2016John H. WeilandCOOSell1,618$187.45$303,294.10View SEC Filing  
2/17/2016Timothy M. RingCEOSell2,453$187.62$460,231.86View SEC Filing  
2/17/2016Timothy P. CollinsinsiderSell974$187.48$182,605.52View SEC Filing  
2/16/2016Anthony WeltersDirectorSell1,784$187.47$334,446.48View SEC Filing  
2/12/2016Christopher S. HollandCFOSell6,297$181.08$1,140,260.76View SEC Filing  
2/12/2016John A. DefordVPSell6,400$182.40$1,167,360.00View SEC Filing  
2/12/2016John H. WeilandCOOSell15,632$182.86$2,858,467.52View SEC Filing  
2/12/2016Timothy M. RingCEOSell24,003$182.76$4,386,788.28View SEC Filing  
2/12/2016Timothy P. CollinsinsiderSell7,893$182.28$1,438,736.04View SEC Filing  
2/10/2016John P. GroetelaarsinsiderSell3,319$187.16$621,184.04View SEC Filing  
2/9/2016John A. DefordVPSell3,407$180.62$615,372.34View SEC Filing  
2/9/2016John H. WeilandCOOSell8,898$181.10$1,611,427.80View SEC Filing  
2/9/2016Timothy M. RingCEOSell4,836$181.20$876,283.20View SEC Filing  
2/9/2016Timothy P. CollinsinsiderSell4,205$181.24$762,114.20View SEC Filing  
2/2/2016Tommy G ThompsonDirectorSell2,319$188.75$437,711.25View SEC Filing  
12/16/2015John H. WeilandCOOSell19,686$188.49$3,710,614.14View SEC Filing  
12/16/2015Patricia G ChristianVPSell1,908$190.00$362,520.00View SEC Filing  
12/14/2015Jim C. BeasleyinsiderSell20,577$184.78$3,802,218.06View SEC Filing  
12/14/2015John A. DefordVPSell5,627$184.00$1,035,368.00View SEC Filing  
12/14/2015John H. WeilandCOOSell33,569$184.25$6,185,088.25View SEC Filing  
11/30/2015Timothy M. RingCEOSell22,052$187.37$4,131,883.24View SEC Filing  
10/29/2015Timothy M. RingCEOSell30,543$184.79$5,644,040.97View SEC Filing  
10/27/2015Gail K. NaughtonDirectorSell2,458$181.99$447,331.42View SEC Filing  
9/29/2015Timothy M. RingCEOSell40,000$185.16$7,406,400.00View SEC Filing  
8/31/2015Timothy M. RingCEOSell40,000$195.17$7,806,800.00View SEC Filing  
8/18/2015Sharon M. LuboffVPSell2,374$199.76$474,230.24View SEC Filing  
8/17/2015Sharon M LuboffVPSell2,030$200.00$406,000.00View SEC Filing  
8/14/2015Tommy G ThompsonDirectorSell1,200$199.25$239,100.00View SEC Filing  
7/13/2015John P GroetelaarsInsiderSell2,456$175.00$429,800.00View SEC Filing  
7/13/2015Timothy M RingCEOSell20,000$176.04$3,520,800.00View SEC Filing  
4/28/2015Tommy G ThompsonDirectorSell1,200$170.43$204,516.00View SEC Filing  
3/23/2015Timothy M RingCEOSell7,628$170.65$1,301,718.20View SEC Filing  
2/23/2015Timothy M RingCEOSell20,000$176.33$3,526,600.00View SEC Filing  
2/19/2015Jim C BeasleyInsiderSell2,884$174.79$504,094.36View SEC Filing  
2/19/2015John H WeilandCOOSell8,413$174.99$1,472,190.87View SEC Filing  
2/19/2015John P GroetelaarsVPSell4,566$175.14$799,689.24View SEC Filing  
2/17/2015Jim C BeasleyInsiderSell9,904$174.58$1,729,040.32View SEC Filing  
2/17/2015John A DefordVPSell6,146$174.58$1,072,968.68View SEC Filing  
2/17/2015John H WeilandCOOSell13,616$174.51$2,376,128.16View SEC Filing  
2/17/2015Timothy M RingCEOSell6,284$174.75$1,098,129.00View SEC Filing  
2/12/2015Patricia G ChristianVPSell1,408$173.97$244,949.76View SEC Filing  
2/12/2015Timothy M RingCEOSell14,363$173.74$2,495,427.62View SEC Filing  
2/12/2015Timothy P CollinsInsiderSell6,564$174.00$1,142,136.00View SEC Filing  
2/9/2015Anthony WeltersDirectorSell1,563$169.02$264,178.26View SEC Filing  
1/22/2015Timothy M RingCEOSell20,000$177.84$3,556,800.00View SEC Filing  
12/22/2014Timothy M RingCEOSell32,325$169.64$5,483,613.00View SEC Filing  
12/17/2014Jim C BeasleyInsiderSell4,525$168.42$762,100.50View SEC Filing  
12/17/2014Sharon M LuboffVPSell3,564$168.36$600,035.04View SEC Filing  
12/16/2014Jim C BeasleyInsiderSell14,634$167.47$2,450,755.98View SEC Filing  
12/16/2014John A DefordVPSell5,626$167.47$942,186.22View SEC Filing  
12/16/2014John H WeilandCOOSell23,093$166.74$3,850,526.82View SEC Filing  
12/16/2014Timothy M RingCEOSell15,232$166.60$2,537,651.20View SEC Filing  
12/15/2014John H WeilandCOOSell13,589$166.56$2,263,383.84View SEC Filing  
12/10/2014Patricia G ChristianVPSell1,269$169.20$214,714.80View SEC Filing  
12/9/2014John H WeilandCOOSell6,350$170.32$1,081,532.00View SEC Filing  
12/9/2014Timothy M RingCEOSell9,550$170.20$1,625,410.00View SEC Filing  
10/27/2014Sharon M LuboffVPSell10,000$158.80$1,588,000.00View SEC Filing  
10/22/2014Timothy M RingCEOSell60,000$149.07$8,944,200.00View SEC Filing  
10/6/2014Timothy M RingCEOSell60,000$148.00$8,880,000.00View SEC Filing  
9/10/2014John H WeilandCOOSell27,179$149.50$4,063,260.50View SEC Filing  
9/2/2014Timothy M RingCEOSell10,228$148.83$1,522,233.24View SEC Filing  
8/4/2014Bronwen K KellyVPSell10,055$150.25$1,510,763.75View SEC Filing  
8/1/2014Timothy M RingCEOSell10,231$149.04$1,524,828.24View SEC Filing  
7/30/2014Timothy P CollinsInsiderSell30,914$150.38$4,648,847.32View SEC Filing  
7/29/2014Sharon M LuboffVPSell5,115$151.37$774,257.55View SEC Filing  
7/1/2014Timothy M RingCEOSell10,231$144.30$1,476,333.30View SEC Filing  
6/2/2014Timothy M RingCEOSell10,231$147.50$1,509,072.50View SEC Filing  
3/3/2014Timothy RingCEOSell10,231$142.23$1,455,155.13View SEC Filing  
2/27/2014Sharon LuboffVPSell9,914$144.86$1,436,142.04View SEC Filing  
2/20/2014Frank Lupisella, Jr.VPSell2,520$140.26$353,455.20View SEC Filing  
2/18/2014Marc BreslawskyDirectorSell2,400$141.34$339,216.00View SEC Filing  
2/11/2014John WeilandCOOSell9,328$135.32$1,262,264.96View SEC Filing  
2/11/2014Sharon LuboffVPSell1,400$135.00$189,000.00View SEC Filing  
1/16/2014John WeilandCOOSell81,500$136.13$11,094,595.00View SEC Filing  
1/13/2014Sharon LuboffVPSell2,500$135.00$337,500.00View SEC Filing  
12/12/2013Jim BeasleyInsiderSell9,802$133.98$1,313,271.96View SEC Filing  
12/12/2013John DefordVPSell2,792$133.98$374,072.16View SEC Filing  
12/10/2013John WeilandCOOSell10,389$137.30$1,426,409.70View SEC Filing  
12/10/2013Timothy RingCEOSell15,623$137.12$2,142,225.76View SEC Filing  
12/2/2013Timothy RingCEOSell10,231$138.85$1,420,574.35View SEC Filing  
11/6/2013David BarrettDirectorSell1,600$138.13$221,008.00View SEC Filing  
10/28/2013Herbert L HenkelDirectorSell2,400$134.66$323,184.00View SEC Filing  
10/28/2013Sharon M AlterioVPSell14,002$134.91$1,889,009.82View SEC Filing  
10/23/2013John H WeilandCOOSell60,210$134.01$8,068,742.10View SEC Filing  
10/21/2013John H WeilandCOOSell84,525$125.62$10,618,030.50View SEC Filing  
10/21/2013Timothy M RingCEOSell8,313$125.52$1,043,447.76View SEC Filing  
10/18/2013Gary D DolchVPSell10,000$125.00$1,250,000.00View SEC Filing  
9/24/2013Timothy RingCEOSell8,313$117.77$979,022.01View SEC Filing  
9/9/2013John A DefordVPSell28,364$117.89$3,343,831.96View SEC Filing  
9/3/2013Timothy RingCEOSell10,231$114.65$1,172,984.15View SEC Filing  
8/30/2013Jim BeasleyInsiderSell1,420$115.33$163,768.60View SEC Filing  
8/21/2013Timothy RingCEOSell8,313$113.24$941,364.12View SEC Filing  
8/12/2013Sharon AlterioVPSell13,379$117.01$1,565,476.79View SEC Filing  
8/5/2013Brian P KellyVPSell28,000$115.69$3,239,320.00View SEC Filing  
8/2/2013David M BarrettDirectorSell1,200$115.70$138,840.00View SEC Filing  
8/2/2013Frank Lupisella JrVPSell10,500$115.61$1,213,905.00View SEC Filing  
8/1/2013John H WeilandCOOSell87,336$115.35$10,074,207.60View SEC Filing  
7/29/2013Timothy P CollinsInsiderSell22,025$113.60$2,502,040.00View SEC Filing  
7/26/2013Anthony WeltersDirectorSell5,600$113.12$633,472.00View SEC Filing  
7/26/2013Jean F HollowayVPSell2,275$113.52$258,258.00View SEC Filing  
7/22/2013Timothy M RingCEOSell8,312$113.58$944,076.96View SEC Filing  
6/21/2013Timothy M RingCEOSell8,312$110.05$914,735.60View SEC Filing  
6/20/2013Gary D DolchVPSell14,569$109.97$1,602,152.93View SEC Filing  
5/21/2013Timothy M RingCEOSell8,312$106.65$886,474.80View SEC Filing  
5/20/2013Marc C BreslawskyDirectorSell2,400$107.20$257,280.00View SEC Filing  
5/8/2013Timothy M RingCEOSell8,312$102.00$847,824.00View SEC Filing  
4/11/2013G Mason MorfitInsiderSell300,000$102.47$30,741,000.00View SEC Filing  
4/9/2013Timothy M RingCEOSell8,312$102.00$847,824.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for C R Bard (NYSE:BCR)
4-traders.com logoMinerals Council of Australia : WTO BREAKTHROUGH ON TRADE FACILITATION AGREEMENT (NYSE:BCR)
www.4-traders.com - February 22 at 8:54 PM
marketexclusive.com logoInsider Trading Activity C R Bard Inc (NYSE:BCR) – Insider Sold 4,390 shares of Stock (NYSE:BCR)
marketexclusive.com - February 22 at 8:54 PM
realistinvestor.com logoMean Rating Of CR Bard, Inc. (NYSE:BCR) At $2.37 - RealistInvestor.com (NYSE:BCR)
www.realistinvestor.com - February 22 at 3:53 PM
News IconThe Charts For CR Bard, Inc. (BCR) Is Speaking Volumes Today - NY Stock News (NYSE:BCR)
nystocknews.com - February 22 at 3:53 PM
News IconInvestor Watch: Looking at the Numbers for CR Bard, Inc. (NYSE:BCR) - Providence Standard (NYSE:BCR)
providencestandard.com - February 21 at 4:04 PM
News IconCR Bard, Inc. (NYSE:BCR) Touches New 52-week High - Aiken Advocate (NYSE:BCR)
aikenadvocate.com - February 21 at 11:28 AM
finance.yahoo.com logoBARD C R INC /NJ/ Financials (NYSE:BCR)
finance.yahoo.com - February 17 at 6:17 PM
News IconLooking at the Levels for CR Bard, Inc. (NYSE:BCR) - Rives Journal (NYSE:BCR)
rivesjournal.com - February 14 at 8:32 PM
realistinvestor.com logoCR Bard, Inc. (NYSE:BCR) Mean Rating At $2.37 - RealistInvestor.com (NYSE:BCR)
www.realistinvestor.com - February 14 at 3:29 PM
biz.yahoo.com logoBARD C R INC /NJ/ Files SEC form 10-K, Annual Report (NYSE:BCR)
biz.yahoo.com - February 13 at 9:25 PM
marketexclusive.com logoInsider Trading Activity C.R. Bard, Inc. (NYSE:BCR) – Vice Chairman Sold 14,281 shares of Stock (NYSE:BCR)
marketexclusive.com - February 12 at 8:53 PM
marketexclusive.com logoInsider Trading Activity CR Bard, Inc. (NYSE:BCR) – Insider Sold 8593 shares of Stock - Market Exclusive (NYSE:BCR)
marketexclusive.com - February 12 at 3:52 PM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: C. R. Bard, Illinois Tool Works, Sherwin-Williams, Cintas and S&P Global (NYSE:BCR)
finance.yahoo.com - February 3 at 4:02 PM
capitalcube.com logoETFs with exposure to C.R. Bard, Inc. (New Jersey) : February 2, 2017 (NYSE:BCR)
www.capitalcube.com - February 2 at 3:58 PM
News IconOak Associates LTD Lowered Its Bard C R INC Com (BCR) Position as Stock Value Declined (NYSE:BCR)
randolphguide.com - February 1 at 4:01 PM
marketexclusive.com logoInsider Trading Activity C.R. Bard, Inc. (NYSE:BCR) – Director Sold 367 shares of Stock (NYSE:BCR)
marketexclusive.com - February 1 at 4:01 PM
finance.yahoo.com logoC. R. Bard (BCR): Moving Average Crossover Alert (NYSE:BCR)
finance.yahoo.com - February 1 at 4:01 PM
News IconVictory Capital Management INC Has Lowered Stake in Bard C R INC Com (BCR) as Share Price Declined (NYSE:BCR)
randolphguide.com - January 31 at 4:04 PM
capitalcube.com logoC.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: 2016 By the Numbers : January 30, 2017 (NYSE:BCR)
www.capitalcube.com - January 30 at 4:55 PM
News IconInvestor Focus: Watching Shares of C. R. Bard, Inc. (NYSE:BCR ... - Gilbert Daily (NYSE:BCR)
gilbertdaily.com - January 28 at 8:51 PM
News IconCR Bard, Inc. (NYSE:BCR) to Post $2.73 Earnings Per Share: Analysts - Wall Street Beacon (NYSE:BCR)
wsbeacon.com - January 28 at 3:51 PM
seekingalpha.com logoC. R. Bard, Inc. 2016 Q4 - Results - Earnings Call Slides (NYSE:BCR)
seekingalpha.com - January 27 at 10:21 PM
bloomberg.com logoRecent BCR News (NYSE:BCR)
www.bloomberg.com - January 27 at 5:19 PM
finance.yahoo.com logoC.R. Bard (BCR) Q4 Earnings & Sales Better Than Expected (NYSE:BCR)
finance.yahoo.com - January 27 at 5:19 PM
4-traders.com logoC R Bard : Bard Announces Fourth Quarter Results (NYSE:BCR)
www.4-traders.com - January 27 at 2:31 AM
marketexclusive.com logoAnalyst Activity – BMO Capital Markets Reiterates Buy on C.R. Bard (NYSE:BCR) (NYSE:BCR)
marketexclusive.com - January 27 at 2:31 AM
seekingalpha.com logoC. R. Bard's (BCR) CEO Timothy Ring on Q4 2016 Results - Earnings Call Transcript (NYSE:BCR)
seekingalpha.com - January 27 at 2:31 AM
us.rd.yahoo.com logo4:19 pm C.R. Bard beats by $0.03, beats on revs; guides FY17 EPS above consensus, revs in-line (NYSE:BCR)
us.rd.yahoo.com - January 27 at 2:31 AM
sg.finance.yahoo.com logoC.R. Bard tops Street 4Q forecasts (NYSE:BCR)
us.rd.yahoo.com - January 27 at 2:31 AM
nasdaq.com logoC.R. Bard Inc Q4 Earnings Advance 13% - Nasdaq (NYSE:BCR)
www.nasdaq.com - January 26 at 9:30 PM
streetinsider.com logoCR Bard Inc. (BCR) Tops Q4 EPS by 3c - StreetInsider.com (NYSE:BCR)
www.streetinsider.com - January 26 at 9:30 PM
istreetwire.com logoStocks To Watch: Expedia, Inc. (EXPE), C. R. Bard, Inc. (BCR), Principal Financial Group, Inc. (PFG) - iStreetWire (NYSE:BCR)
istreetwire.com - January 26 at 4:30 PM
biz.yahoo.com logoQ4 2016 C R Bard Inc Earnings Release - After Market Close (NYSE:BCR)
biz.yahoo.com - January 26 at 4:30 PM
biz.yahoo.com logoC R Bard Inc Earnings Call scheduled for 5:00 pm ET today (NYSE:BCR)
biz.yahoo.com - January 26 at 4:30 PM
finance.yahoo.com logoBard Announces Fourth Quarter Results (NYSE:BCR)
finance.yahoo.com - January 26 at 4:30 PM
biz.yahoo.com logoBARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit (NYSE:BCR)
biz.yahoo.com - January 26 at 4:30 PM
News IconEarnings in Full Force, Analysts Take Aim at C.R. Bard, Inc. (NYSE:BCR) - Wall Street Beacon (NYSE:BCR)
wsbeacon.com - January 25 at 4:04 PM
nasdaq.com logoC.R. Bard (BCR) to Report Q4 Earnings: A Surprise in Store? - Nasdaq (NYSE:BCR)
www.nasdaq.com - January 25 at 4:04 PM
News IconWest Coast Financial Boosts Position by $5505991 in C R Bard Inc (BCR) - Highland Mirror (NYSE:BCR)
www.highlandmirror.com - January 25 at 4:04 PM
finance.yahoo.com logoC.R. Bard (BCR) to Report Q4 Earnings: A Surprise in Store? (NYSE:BCR)
finance.yahoo.com - January 23 at 4:13 PM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: C. R. Bard, Inc. (NYSE:BCR) - Wall Street Beacon (NYSE:BCR)
wsbeacon.com - January 21 at 3:46 PM
investopedia.com logoC. R. Bard Stock Trades Ex-Dividend Thursday (NYSE:BCR)
www.investopedia.com - January 19 at 4:59 PM
4-traders.com logoC R BARD INC : ex-dividend day (NYSE:BCR)
www.4-traders.com - January 19 at 2:35 AM
News IconWill The Needle Move For C.R. Bard, Inc. (NYSE:BCR) Shares This Earnings Season? - Wall Street Beacon (NYSE:BCR)
wsbeacon.com - January 18 at 9:33 PM
News IconFirms & Funds Reinforcing Their Perception of C. R. Bard, Inc. (NYSE:BCR) - Wall Street Beacon (NYSE:BCR)
wsbeacon.com - January 18 at 9:33 PM
nasdaq.com logoC.R. Bard, Inc. (BCR) Ex-Dividend Date Scheduled for January 19, 2017 - Nasdaq (NYSE:BCR)
www.nasdaq.com - January 18 at 9:33 PM
investornewswire.com logoSales Of C.R. Bard, Inc. (NYSE:BCR) Expected At $4501.5 - Investor Newswire (NYSE:BCR)
www.investornewswire.com - January 15 at 3:47 PM
News IconC. R. Bard Inc BCR Medical Equipment Deals and Alliances Profile Prices from USD $250 (NYSE:BCR)
www.bioportfolio.com - January 14 at 3:22 AM
News IconGearing Up For a Bull Run? Analysts Weigh in on C.R. Bard, Inc. (NYSE:BCR) - Wall Street Beacon (NYSE:BCR)
wsbeacon.com - January 13 at 4:29 PM
News IconLarge Outflow of Money Witnessed in C.R. Bard, Inc. - Highland Mirror (NYSE:BCR)
www.highlandmirror.com - January 10 at 3:58 PM


What is C R Bard's stock symbol?

C R Bard trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCR."

How often does C R Bard pay dividends? What is the dividend yield for C R Bard?

C R Bard declared a quarterly dividend on Wednesday, December 14th. Stockholders of record on Monday, January 23rd will be paid a dividend of $0.26 per share on Friday, February 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date of this dividend is Thursday, January 19th.

Where is C R Bard's stock going? Where will C R Bard's stock price be in 2017?

15 brokers have issued twelve-month price targets for C R Bard's shares. Their predictions range from $205.00 to $265.00. On average, they expect C R Bard's stock price to reach $242.38 in the next twelve months.

When will C R Bard announce their earnings?

C R Bard is scheduled to release their next quarterly earnings announcement on Tuesday, April, 25th 2017.

What are analysts saying about C R Bard stock?

Here are some recent quotes from research analysts about C R Bard stock:

  • According to Zacks Investment Research, "C. R. Bard reported stellar fourth-quarter 2016 results, crushing the Zacks Consensus Estimate on both counts, courtesy of growth from each of its four businesses both domestically and internationally. Over the past one year, C. R. Bard has outperformed the broader industry trends with respect to price performances. The company has gained prominence in the market with an expanding product portfolio and continuing regulatory approvals. The growing adoption of Lutonix DCB is expected to drive top-line growth in the coming quarters. Meanwhile, solid performance by the company’s vascular product, oncology, surgical specialties and urology platforms are encouraging. Also, a rising estimate revision trend indicates analysts are becoming more bullish on the stock. Finally, C. R. Bard’s full year 2017 earnings guidance, which reflects a solid year-over increase between 11% and 14%, impressed us." (1/31/2017)

  • Needham & Company LLC analysts commented, "BCR’s 4Q16 revenue and EPS beat consensus and management provided initial 2017 revenue guidance that was in line with consensus and EPS guidance that was above consensus. Organic revenue growth improved to 6.9% in 4Q16 from 6.4% in 3Q16. Although BCR’s gross margin declined slightly, its operating margin improved by 150 bps Y/Y due to significant SG&A leverage." (1/27/2017)

Who owns C R Bard stock?

C R Bard's stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (5.04%), FMR LLC (1.29%), Renaissance Technologies LLC (0.69%), AQR Capital Management LLC (0.68%), Frontier Capital Management Co. LLC (0.65%) and Marshall Wace LLP (0.62%). Company insiders that own C R Bard stock include Anthony Welters, Betty D Larson, Christopher S Holland, Frank Lupisella Jr, Frank Lupisella, Jr, Gail K Naughton, Jim C Beasley, John A Deford, John H Weiland, John P Groetelaars, Patricia G Christian, Sharon M Luboff, Timothy M Ring, Timothy P Collins, Tommy G Thompson and Tony L White.

Who sold C R Bard stock? Who is selling C R Bard stock?

C R Bard's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, AQR Capital Management LLC, Tudor Investment Corp Et Al, Prudential PLC, Numeric Investors LLC, Bessemer Group Inc. and Westwood Holdings Group Inc.. Company insiders that have sold C R Bard stock in the last year include Betty D Larson, Christopher S Holland, Frank Lupisella Jr, Frank Lupisella, Jr, Gail K Naughton, Jim C Beasley, John A Deford, John H Weiland, John P Groetelaars, Sharon M Luboff, Timothy M Ring, Timothy P Collins, Tommy G Thompson and Tony L White.

Who bought C R Bard stock? Who is buying C R Bard stock?

C R Bard's stock was bought by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P., State Street Corp, Asset Management One Co. Ltd., Russell Investments Group Ltd., Marshall Wace LLP, Federated Investors Inc. PA, Broadfin Capital LLC and Janus Capital Management LLC.

How do I buy C R Bard stock?

Shares of C R Bard can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of C R Bard stock cost?

One share of C R Bard stock can currently be purchased for approximately $243.38.

C R Bard (NYSE:BCR) Chart for Thursday, February, 23, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for C R Bard (NYSE:BCR)

Earnings History Chart

Earnings by Quarter for C R Bard (NYSE:BCR)

Dividend History Chart

Dividend Payments by Quarter for C R Bard (NYSE:BCR)

Last Updated on 2/23/2017 by MarketBeat.com Staff